Novo Holdings Reports Strong Momentum in Asia Across Healthcare and Planetary Health in 2024
SINGAPORE, June 18, 2025 /PRNewswire/ -- Novo Holdings today released its Asia Investments Year in Review 2024, highlighting a year of strategic growth and purpose-driven investing across healthcare, life sciences, and planetary health in key Asian markets. The report underscores Novo Holdings' commitment to building long-term partnerships that deliver both financial returns and societal impact.
Now in its fifth year, the Novo Holdings Asia platform continues to strengthen its footprint across the region, with teams based in Singapore, Shanghai, and an upcoming office in Mumbai.
Highlights from 2024 include:
Largest-ever Asia investment in India's Manipal Hospitals, a leading provider of high-quality, affordable healthcare
First Planetary Health investment in Asia, backing AgNext Technologies in India to enhance food quality and safety using AI
Enhanced presence in China with the opening of an expanded office in Shanghai, reaffirming long-term regional commitment
Continued support for digital health innovators, including follow-on investments in Qure.ai and MedGenome
The Year in Review also reflects positive progress across Novo Holdings' Asia portfolio, with key portfolio milestones including FDA clearance for Qure.ai's lung nodule detection tool, strategic acquisitions by Manipal Hospitals and Medi Assist, and the launch of Doctor Anywhere's integrated MedSuites facility in Singapore.
Amit Kakar, Managing Partner and Head of Asia at Novo Holdings, said:"In 2024, we advanced our mission of investing in innovation that improves lives, through strengthening healthcare systems, advancing AI in diagnostics, and enabling more sustainable food production. These investments reflect the scale and urgency of the challenges Asia faces, and the opportunity to be part of transformative solutions.
Looking ahead, we are excited to continue expanding our regional platform, deepening our partnerships, and identifying new ways to drive impact at the intersection of health, science, and sustainability."
Read the full review at: https://novoholdings.dk/news/novo-holdings-reports-strong-momentum-in-asia-across-healthcare-and-planetary-health-in-2024
About Novo HoldingsNovo Holdings is a holding and investment company responsible for managing the assets and wealth of the Novo Nordisk Foundation. The purpose of Novo Holdings is to improve people's health and the sustainability of society and the planet by generating attractive long-term returns on the assets of the Novo Nordisk Foundation. Wholly owned by the Foundation, Novo Holdings is the controlling shareholder of Novo Nordisk A/S and Novonesis A/S (formerly Novozymes A/S) and manages an investment portfolio with a long-term return perspective. In addition to managing a broad portfolio of equities, bonds, real estate, infrastructure, and private equity assets, Novo Holdings is a world-leading life sciences investor. Through its Seed, Venture, Growth, Asia, Planetary Health, and Principal Investments teams, Novo Holdings invests in life sciences companies at all stages of development. As of year-end 2024, Novo Holdings had total assets of EUR 142 billion.www.novoholdings.dk
Further information:
Paul Ewing-ChowHead of Corporate Affairs Asiapec@novo.dk
View original content:https://www.prnewswire.com/apac/news-releases/novo-holdings-reports-strong-momentum-in-asia-across-healthcare-and-planetary-health-in-2024-302484881.html
SOURCE Novo Holdings
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Entrepreneur
28 minutes ago
- Entrepreneur
Keeping Cyber Secure — and Scalable
Opinions expressed by Entrepreneur contributors are their own. You're reading Entrepreneur United Kingdom, an international franchise of Entrepreneur Media. Stephen Kines has been building businesses with his co-founder Tony for over 30 years, but with Goldilock - and its flagship physical cyber product FireBreak - he's scaling a truly global vision. From Wolverhampton to Singapore, his team is tackling one of tech's toughest problems: how to grow fast, stay agile, and never compromise on trust. Entrepreneur UK finds out more. What strategies helped you scale efficiently without compromising quality? My co-founder Tony and I have known each other for over three decades, and we've spent a lot of that time building and scaling businesses. The success stories have consistently been characterised by great people. Hire the best people, empower them to make decisions, learn from setbacks together, and always, always put the customer at the centre of everything you're doing. That's what we've replicated here at Goldilock. We have recruited extremely experienced people to lead our teams globally. Crucially, people who really believe in what we're doing at Goldilock in protecting networks with our physical cyber product, FireBreak. That's how we know they'll consistently make the right decisions for the company. We've also made sure no silos are created between departments as we scale. Keeping our technical team in close contact with our sales, marketing and communications teams has placed the customer at the centre of every decision being made across the board. This means quality of service is never affected and we can maintain the agility we had in the beginning as we're all working to the same end. How did you build and maintain a strong company culture during rapid growth? Goldilock is very much a modern global organisation. We're headquartered in Wolverhampton and the vast majority of our technical team is based there. But in FireBreak we have developed a genuinely new cyber security product that is not only unique but also applicable for every single industry and organisation that uses digital infrastructure, so there was no point in limiting ourselves to launching in just one or two countries or regions. This means the rest of our team is spread out across the globe – from the US to Europe to Singapore to Australia. When you have a scale-up workforce that is so widely dispersed, communication is key. This communication has to be constant and it has to come from the top-down. A main focus when building Goldilock was building a very, very experienced management team. We handpicked a leadership team that not only brought invaluable experience but could make sure each region feels like a cohesive part of the team. Maintaining this cohesive team element as we continue to scale means retaining that startup mindset we had at the beginning, communicating regularly on the direction of the business, getting everyone's buy-in on strategy, and – critically – ensuring no silos ever appear between the technical, sales, marketing and comms teams, as well as our board. We're very lucky that everyone on the team here believes in what we're trying to do at Goldilock and has the same drive and motivation to see this company continue to succeed that Tony and I do. What were the biggest operational challenges you faced while scaling? As with most start-ups, we had to start with a fairly lean team while we went through R&D. Obviously, a small team is great for agility and flexibility – both of which you need a lot of when starting a company. However, it did mean we were spread quite thin. Identifying market opportunities has never been difficult for us with a product that is so applicable across industries, but it then came down to prioritising resources. Using a channel model for sales really helped us here as it allowed us to target various sectors with different needs and pain points – from manufacturing to financial services – without investing too heavily in expertise in-house. The other challenge with a smaller workforce is making sure we don't end up creating bottlenecks. Solving this comes back to choosing great people, empowering them to make decisions and then trusting them to do so. How did you prioritise customer acquisition and retention as you expanded? Since we decided early on that a channel model made sense for us since we sell to so many different types of businesses and organisations, as we've grown, we've worked hard to make sure both our channel partners and end-users truly understand the product and what it can do. We focus on communicating the value FireBreak brings and the ease with which it can be deployed into organisations' existing infrastructure to dramatically reduce their attack surfaces. The key throughout has been making sure both groups – partners and customers – feel totally sure of our support wherever they are in a sales process. What advice would you give a start-up looking to scale in a competitive market? You have to really believe in what you do and then find other people who also genuinely believe in it to join you; experienced colleagues you don't need to persuade to join you end up being the most dedicated workers and best advocates when helping to build your brand and sell to prospects and investors. It's so easy for silos to pop up between departments as you build them out, but if everyone is clear on what the company is trying to achieve as well as the why and the how, everything should be moving together towards the same objective. Then it's all about having a laser focus on your USP. Focusing on what makes us unique and pioneering has got us to where we are today. Ask yourself – what challenge are you solving, what differentiates your solution, and why should it matter to your customers? Building your company around the answers to these questions will help you keep customers at the heart of your decision-making and also help you communicate consistently with external stakeholders as you scale. How have UK trade policies influenced your international expansion and scaling efforts? More accessible export finance solutions for the startup community could help to further accelerate the international reach of pioneering UK technologies like ours and help home-grown startups more easily scale and succeed. Beyond that, to be honest, UK trade policies haven't had too much of an effect on our ability to grow globally. In fact, we have been fortunate enough to work closely with some government departments as we've scaled because of the huge potential of FireBreak in protecting critical infrastructure. The UK's Business & Trade team and the Defence & Security Exports team in particular are excellent – we have been on trade missions and to UK Embassies and High Commissions such as recently in Singapore. The MoD's Defence and Security Accelerator (DASA) and Innovate UK have also been very supportive.
Yahoo
29 minutes ago
- Yahoo
Obvious Losers, Unexpected Winners As Tax Bill Passes Senate
Clean energy stocks delivered mixed performances on Wednesday as investors continued digesting the Senate's surprise revisions to President Trump's 'big, beautiful bill.' Utility-scale solar firms remained under pressure, while residential solar, hydrogen, and U.S.-based battery storage companies extended gains amid signs the legislation favors domestic supply chains and penalizes projects linked to China. NextEra Energy (NYSE:NEE) slipped another 1.2% on Wednesday, compounding earlier losses, while AES Corp. (NYSE:AES) closed flat after a two-day decline of more than 6%. Shoals Technologies (NASDAQ:SHLS), already down over 14% on Monday, dropped another 3.6% Wednesday. Nextracker (NASDAQ:NXT) slid 2.4%, and Enphase Energy (NASDAQ:ENPH) shed another 4.2%, extending its weekly decline past 15%. Array Technologies (NASDAQ:ARRY) was down 1.8% Wednesday, failing to recover from Monday's -10.1% plunge, as investors reassessed the near-term pipeline risk from the new operational deadline for tax credit eligibility. But There Are Winners, Too … Sunrun (NASDAQ:RUN) added 2.7% Wednesday, bringing its weekly gain to nearly 17% as markets priced in a more favorable outlook for distributed solar. First Solar (NASDAQ:FSLR) advanced another 1.5% on the day following two strong sessions. Analysts at Jefferies upgraded the stock, calling it a key winner from U.S. content incentives and tariffs on Chinese materials. Fluence Energy (NASDAQ:FLNC) and Eos Energy Enterprises (NASDAQ:EOSE), both operating battery storage projects in the U.S., gained 3.1% and 2.5% respectively. As noted here, traders continue rotating into companies best positioned to meet the new sourcing and operations deadlines. And Hydrogen is getting a boost, as well. Hydrogen stocks surged for a third straight session after the Senate unexpectedly extended the 45V clean hydrogen production tax credit to 2027. Plug Power (NASDAQ:PLUG) soared another 8.2% Wednesday, bringing its three-day gain to more than 40%. Bloom Energy (NYSE:BE) added 3.4%, and Ballard Power Systems (NASDAQ:BLDP) rose 2.2%, supported by increasing optimism that delayed U.S. hydrogen projects will now move forward under more favorable terms. Coal, nuclear, and legacy energy stocks have also caught the tailwinds. Steelmaking coal producers continued to gain on Wednesday after the bill granted critical minerals tax credit eligibility to metallurgical coal. Alpha Metallurgical Resources (NYSE:AMR) rose 1.9%, Warrior Met Coal (NYSE:HCC) added 2.4%, and Peabody Energy (NYSE:BTU) was up 1.5%. Meanwhile, uranium and nuclear-linked equities also saw light buying as the bill preserved tax credits for non-carbon baseload power including nuclear, hydro, and geothermal. Cameco (NYSE:CCJ) and Constellation Energy (NASDAQ:CEG) rose modestly, up 0.7% and 1.1% respectively. Policy In the Volatility Driver's Seat The Senate bill tightens tax credit qualification rules by requiring renewable projects to be operational by 2027, rather than just under construction. It also levies new taxes on projects that use Chinese-sourced materials and allows some carveouts for clean hydrogen and domestic manufacturers. According to Rhodium Group estimates, the combination of tax loss and China-linked penalties could raise project costs by up to 20%, with developers likely to pass that through in electricity prices. The American Clean Power Association warned of an 8–10% rise in consumer electricity bills if the proposal is enacted. With the bill headed back to the House for reconciliation, market participants are bracing for additional volatility. Fiscal conservatives are expected to contest the Senate version's deficit impact—estimated to add roughly $1 trillion more than the House-passed bill from May. For now, traders are positioning around likely winners with U.S.-centric supply chains, while pricing in risk for utility-scale developers with international exposure. By Alex Kimani for More Top Reads From this article on
Yahoo
29 minutes ago
- Yahoo
5 Must-Read Analyst Questions From Limbach's Q1 Earnings Call
Limbach's first quarter performance was met with a positive market reaction, reflecting the company's ability to outperform Wall Street expectations on both revenue and adjusted profits. Management attributed the robust results to the ongoing shift towards owner-direct relationships, with the Owner Direct Relationship (ODR) segment now making up nearly 68% of revenue. CEO Michael McCann highlighted the company's focus on building long-term partnerships with customers, particularly in the healthcare sector, which benefited from rising demand for deferred maintenance and infrastructure upgrades. McCann also noted the impact of recent investments in sales personnel, stating, 'This investment is an important step in the continued evolution of our relationship with our customers.' Is now the time to buy LMB? Find out in our full research report (it's free). Revenue: $133.1 million vs analyst estimates of $121.1 million (11.9% year-on-year growth, 10% beat) Adjusted EPS: $1.12 vs analyst estimates of $0.43 (significant beat) Adjusted EBITDA: $14.87 million vs analyst estimates of $10.34 million (11.2% margin, 43.8% beat) The company reconfirmed its revenue guidance for the full year of $620 million at the midpoint EBITDA guidance for the full year is $80 million at the midpoint, above analyst estimates of $78.6 million Operating Margin: 6.3%, in line with the same quarter last year Market Capitalization: $1.58 billion While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention. Rob Brown (Lake Street Capital): Brown asked about the healthcare vertical's rebound and how deferred maintenance is impacting project activity. CEO Michael McCann described a 'slow ramp up' as hospitals prioritize long-term capital planning, supported by stable demand. Rob Brown (Lake Street Capital): Brown also questioned the effect of tariffs and whether project pull-forwards pose a risk. McCann stated that tariffs have been neutral so far, with the company's nimble model allowing quick cost pass-through and rapid project cycles. Chris Moore (CJS Securities): Moore inquired about the criteria for assigning account managers to ODR clients and the process for developing deep partnerships. McCann explained that account managers are deployed after careful analysis of client potential, with a focus on scaling local relationships to national accounts. Gerry Sweeney (ROTH Capital Partners): Sweeney sought details about the ramp-up and integration of new sales hires. McCann indicated that most new hires are onsite account managers, with a typical ramp dependent on client type and sales role. Brian Brophy (Stifel): Brophy asked if the acceleration seen in March was above normal seasonality and about recent industry disruptions. McCann attributed the uptick to both seasonality and the impact of new sales personnel, while noting that equipment transitions from regulatory changes can create decision points for customers. Looking forward, our analysts will be watching (1) the pace of ODR revenue growth and the ability to increase its share of total sales, (2) the effectiveness of new sales hires in winning recurring and higher-margin business, and (3) progress on geographic expansion through both acquisitions and organic growth. Additionally, integration success of recent acquisitions and responsiveness to tariff or input cost volatility will be key markers of execution. Limbach currently trades at $136.63, up from $103.13 just before the earnings. In the wake of this quarter, is it a buy or sell? See for yourself in our full research report (it's free). Donald Trump's victory in the 2024 U.S. Presidential Election sent major indices to all-time highs, but stocks have retraced as investors debate the health of the economy and the potential impact of tariffs. While this leaves much uncertainty around 2025, a few companies are poised for long-term gains regardless of the political or macroeconomic climate, like our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025). Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today. Sign in to access your portfolio
